ABSTRACT DEADLINE 14 SEPTEMBER

Abstract Review
After the Sept 14 deadline, abstracts will be reviewed by the Scientific Programming Committee.  You will be notified via email as to whether your abstract has been accepted by September 25, 2020.

  1. Each abstract is reviewed by 2 reviewers. This review step is blinded and strictly confidential. Each reviewer scores the abstracts independently, without knowledge of the name(s) and institution(s) of the submitter(s) or the scores given by the other reviewers.
  2. The accepted abstracts are assigned a number and scheduled date/time.
  3. The top-scoring Trainee abstracts will be eligible for an award. A Trainee must be graduate student, fellow, postdoc, etc
  4. PGRN reserves the right to decline a presentation to any submitted abstracts that lack scientific content or merit, or that merely announce the availability of a resource or service.

Abstract Submission Instructions
The Presenting Author must be registered to submit an abstract.

Upload your abstract in .pdf format when you register or send to info@pgrn.org by the
deadline of Sept 14

Name your file:       Last Name-First Name
Abstract Format: 
   Title of Abstract
Abstract Authors:   Listed in order they should appear in printed       
                              materials. Indicate the Presenting Author with a *

Author Institution
:  List in order
Summary:              Limit to 500 words.  Do not include tables or figures

 









Copyright © 2020 the Pharmacogenomics Research Network. All Rights Reserved.

Follow us on


Become a Member

PGRN logo
Membership dues are vital to continue the mission and work of the PGRN. Founding Members will be listed on the PGRN website. 
Powered by Wild Apricot Membership Software